Azitra Inc

📍 Branford, United States🗓 Founded 2014👥 12 employees💰 Last funded Sep 2020
Biotechnology🌐 azitrainc.com
Website LinkedIn
Azitra, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. Azitra’s lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. ATR-04, Azitras additional clinical program, utilizes another engineered strain of S. epidermidis for the treatment of EGFR inhibitor ("EGFRi") associated skin toxicity. The ATR-12 and ATR-04 programs were developed from Azitras proprietary platform of engineered proteins and topical live biotherapeutic products that includes a microbial library comprised of approximately 1,500 bacterial strains. The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. For more information visit www.azitrainc.com.
3
Total investors
0
Early stage
2
Mid stage
1
Late stage
2014
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2018–2020 · investors recorded per year
201812019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Azitra Inc?
Azitra Inc has 3 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Azitra Inc last raise funding?
The most recent investment in Azitra Inc recorded on gritt.io was in September 2020.
When was Azitra Inc founded?
Azitra Inc was founded in 2014.
What industry is Azitra Inc in?
Azitra Inc operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Azitra Inc based?
Azitra Inc is headquartered in Branford, United States.